SEARCH RESULTS

Results for "Research"

18. Shalom Lloyd of Emerging Markets Quality Trials: Transforming Healthcare through Research in Africa

Shalom Lloyd,  after a career of over 20 years in the pharmaceutical industry, went on to found two businesses. She is founder of Naturally Tribal skincare, a beauty line based on traditional remedies including shea butter, which she developed initially to cure her son’s eczema. She is also the co-founder and Chief Strategy Officer of eMQT, described as “the Bridge between the Pharmaceutical Industry and Africa” which facilitates clinical trials for pharmaceutical companies in Africa. She has been a keynote speaker on the topic of innovation and was a fellow of the Start-Up Leadership Program in London until 2020. 

9. Shalom Lloyd of Emerging Markets Quality Trials: Transforming Healthcare through Research in Africa

Shalom Lloyd,  after a career of over 20 years in the pharmaceutical industry, went on to found two businesses. She is founder of Naturally Tribal skincare, a beauty line based on traditional remedies including shea butter, which she developed initially to cure her son’s eczema. She is also the co-founder and Chief Strategy Officer of eMQT, described as “the Bridge between the Pharmaceutical Industry and Africa” which facilitates clinical trials for pharmaceutical companies in Africa. She has been a keynote speaker on the topic of innovation and was a fellow of the Start-Up Leadership Program in London until 2020. 

245. Randy Cohen, Senior Lecturer at Harvard Business School – Dangerous Vision in Stock Markets and Venture Capital

Randy Cohen, is a Senior Lecturer at Harvard Business school.  His main research focus is the interface between the actions of institutional investors and price levels in the stock market and has helped to start and grow a number of investment management firms.  He is a partner at Exsight Capital, a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions. This has particular resonance for Randy, who is blind from retinitis pigmentosa.

Trailer Series 2 of 2024: Wealth & Wellness, and Determining the Hero of the Story

We are thrilled to be back with Series 2 of the 2024 Fiftyfaces Podcast, which will marry insights from private wealth with insights on strategy, leadership and the investment landscape. Inter-dsiplinary learning is the way of the future, so we are excited to weave together diverse aspects of our investment discipline here. Series 2 is rich with insights around private wealth, 

Vice Provost Orla Shiels of Trinity College Dublin – Micro Credentials with Macro Impact

Professor Orla Sheils is the Vice-Provost and Chief Academic Officer at Trinity College Dublin as well as holding the position of Professor of Molecular Diagnostics. Prior to her appointment as Vice-Provost in 2021, Orla served as the Director of Medical Ethics in the School of Medicine, was the founding Director of the Trinity Translational Medicine Institute, and was Dean of the Faculty of Health Sciences from 2019-2021. Most recently, Orla was elected as a member of Scientific Council of the International Agency for Research on Cancer for 2024-27. IARC is a cancer research agency of the World Health Organisation that supports cancer prevention research.

242. Daniele Beasley on Financial Therapy – What is it, Why is it Important?

We first interviewed Daniele Beasley in 2021 and discussed her focus on financial literacy and her financial advisory practice.  Fast forward to early 2024, and Daniele’s contribution of content to the industry has continued apace, and she is now making a name for herself in the emerging area of financial therapy. 

213. BONUS Cathie Wood of ARK: Going Back to the Future with AI

Cathie Wood is CEO of ARK Investment Management LLC (“ARK”). Prior to ARK, Cathie spent twelve years at AllianceBernstein as Chief Investment Officer of Global Thematic Strategies where she managed $5 billion. Cathie joined Alliance Capital from Tupelo Capital Management, a hedge fund she co-founded which, in 2000, where she managed $800 million in global thematic strategies. Prior to her tenure at Tupelo Capital, she worked for 18 years with Jennison Associates as Chief Economist, Equity Research Analyst, Portfolio Manager and Director. She started her career in Los Angeles, California at The Capital Group as an Assistant Economist.